BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12531810)

  • 21. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
    Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
    Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells.
    Chen Y; McMillan-Ward E; Kong J; Israels SJ; Gibson SB
    Cell Death Differ; 2008 Jan; 15(1):171-82. PubMed ID: 17917680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
    Pelicano H; Carew JS; McQueen TJ; Andreeff M; Plunkett W; Keating MJ; Huang P
    Leukemia; 2006 Apr; 20(4):610-9. PubMed ID: 16482209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
    Sturlan S; Baumgartner M; Roth E; Bachleitner-Hofmann T
    Blood; 2003 Jun; 101(12):4990-7. PubMed ID: 12609832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZGDHu-1 and fludarabine have a synergistic effect on apoptosis of chronic lymphocytic leukemia cells.
    Qiu L; Liu J; Wang Z; Hu W; Huang Q; Zhou Y
    Oncol Rep; 2015 Sep; 34(3):1239-48. PubMed ID: 26165829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superoxide dismutase as a target for the selective killing of cancer cells.
    Huang P; Feng L; Oldham EA; Keating MJ; Plunkett W
    Nature; 2000 Sep; 407(6802):390-5. PubMed ID: 11014196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic effects of B lymphocytes mediated by reactive oxygen species.
    Villamor N; Montserrat E; Colomer D
    Curr Pharm Des; 2004; 10(8):841-53. PubMed ID: 15040354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria.
    Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
    Nutr Cancer; 2016; 68(8):1404-1416. PubMed ID: 27779444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.
    Bruno S; Ghiotto F; Tenca C; Mazzarello AN; Bono M; Luzzi P; Casciaro S; Recchia A; Decensi A; Morabito F; Fais F
    Leukemia; 2012 Oct; 26(10):2260-8. PubMed ID: 22475870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40 stimulation sensitizes CLL cells to rituximab-induced cell death.
    Jak M; van Bochove GG; van Lier RA; Eldering E; van Oers MH
    Leukemia; 2011 Jun; 25(6):968-78. PubMed ID: 21403646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
    Byrd JC; Shinn C; Willis CR; Flinn IW; Lehman T; Sausville E; Lucas D; Grever MR
    Exp Hematol; 2001 Jun; 29(6):703-8. PubMed ID: 11378265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
    Chang YF; Chi CW; Chern YT; Wang JJ
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):1-12. PubMed ID: 15589971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells.
    Qiu LN; Zhou YL; Wang ZN; Huang Q; Hu WX
    Int J Oncol; 2012 Aug; 41(2):533-40. PubMed ID: 22581170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
    Hayden RE; Pratt G; Davies NJ; Khanim FL; Birtwistle J; Delgado J; Pearce C; Sant T; Drayson MT; Bunce CM
    Leukemia; 2009 Feb; 23(2):292-304. PubMed ID: 18923439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
    Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia.
    Hong M; Xia Y; Zhu Y; Zhao HH; Zhu H; Xie Y; Fan L; Wang L; Miao KR; Yu H; Miao YQ; Wu W; Zhu HY; Chen YY; Xu W; Qian SX; Li JY
    Leuk Res; 2016 Nov; 50():72-77. PubMed ID: 27693855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.